New research links sphingolipids to heart disease and atherosclerosis

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

Atara to file T cell immunotherapy in the US in 2024; RayzeBio closes $358M IPO

Atara Biotherapeutics said Tuesday that it plans to submit its T cell immunotherapy for approval in the US next year. The therapy was approved last

September 21, 2023

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech intends to advance a prophylactic mRNA-based Mpox vaccine with an encouraging safety profile that can be produced at scale. Credit: Marcus Krauss/Shutterstock.com. BioNTech has

September 19, 2023

Unhealthy maternal diet may lead to heart and diabetes risks in offspring

Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.